Thursday August 6, 2020

Pharma: Results to pave way for auction at Elan

Investors will be expecting an update on the sale of Elan when the drug company reports its second-quarter results on Wednesday.

20th July, 2013
Kelly Martin of Elan.

Investors will be expecting an update on the sale of Elan when the drug company reports its second-quarter results on Wednesday.

The company is not expected to entertain any bids until after the results, but speculation has swirled around the company since Royalty Pharma abandoned its hostile takeover approach in June, leaving the way open for an auction process. In the meantime, there has been lots of activity in the stock as institutional shareholders trade...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

The best writing and and the biggest stories of 2019 from the Business Post

Richie Oakley | 7 months ago

Denis O’Brien is back in court, residents continue to fight the Council on halting site and a row surfaces in government over rent control proposals

Leanna Byrne | 4 years ago